Skip to content
MedsAcross

Medicine

Omeprazole 10 mg delayed-release capsule

Omeprazole · Oral
Available on requestPrescription onlyUS FDAGeneric name

Omeprazole 10 mg delayed-release capsule is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store omeprazole delayed-release capsules in a tight container protected from…

Key facts

Active ingredient (INN)
Omeprazole
Brand
Sold under the generic name
Strength
10 mg
Dosage form
Delayed-release capsule
Route
Oral
Packs
100 capsules, 1000 capsules, 30 capsules and 71 more
Manufacturers
Zydus LifesciencesIndiaDr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaGlenmark PharmaceuticalsIndiaCamber PharmaceuticalsIndiaSandozChartwell RXApotexLannett16 labelers on the register
Origin register
US FDA, United States
Storage
Store omeprazole delayed-release capsules in a tight container protected from light and moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A02BC01 Omeprazole
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 January 2003
Identifiers
RxCUI 198051, 199119, 200329DailyMed set ID 0c6e00a2-31e8-4e84-928d-80e69a5fc634, 10f5502a-2e63-4f2a-a3ba-ddc5bd403051, 9c41bcfa-b08b-3ac3-e053-2a95a90ae1c0 +23NDC 31722-527, 62135-530, 76420-878 +23Application ANDA204012, ANDA075410, ANDA091672 +7

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 16 labelers. The register lists 74 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 capsule, delayed release in 1 bottle55111-157-01Dr. Reddy's LaboratoriesIndia21 January 2009
1000 capsule, delayed release in 1 bottle55111-157-10Dr. Reddy's LaboratoriesIndia21 January 2009
30 capsule, delayed release in 1 bottle55111-157-30Dr. Reddy's LaboratoriesIndia21 January 2009
10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack55111-157-78Dr. Reddy's LaboratoriesIndia21 January 2009
100 capsule, delayed release in 1 bottle55111-643-01Dr. Reddy's LaboratoriesIndia9 March 2026
500 capsule, delayed release in 1 bottle55111-643-05Dr. Reddy's LaboratoriesIndia1 March 2014
30 capsule, delayed release in 1 bottle55111-643-30Dr. Reddy's LaboratoriesIndia9 March 2026
10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack55111-643-78Dr. Reddy's LaboratoriesIndia1 March 2014
100 capsule, delayed release in 1 bottle65841-759-01Zydus LifesciencesIndia23 November 2012
500 capsule, delayed release in 1 bottle65841-759-05Zydus LifesciencesIndia23 November 2012
30 capsule, delayed release in 1 bottle65841-759-06Zydus LifesciencesIndia23 November 2012
1000 capsule, delayed release in 1 bottle65841-759-10Zydus LifesciencesIndia23 November 2012
90 capsule, delayed release in 1 bottle65841-759-16Zydus LifesciencesIndia23 November 2012
100 capsule, delayed release in 1 bottle68382-411-01Zydus LifesciencesIndia23 November 2012
500 capsule, delayed release in 1 bottle68382-411-05Zydus LifesciencesIndia23 November 2012
30 capsule, delayed release in 1 bottle68382-411-06Zydus LifesciencesIndia23 November 2012
1000 capsule, delayed release in 1 bottle68382-411-10Zydus LifesciencesIndia23 November 2012
90 capsule, delayed release in 1 bottle68382-411-16Zydus LifesciencesIndia23 November 2012
100 capsule, delayed release in 1 bottle59651-001-01Aurobindo PharmaIndia19 August 2015
3 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack59651-001-03Aurobindo PharmaIndia19 August 2015
30 capsule, delayed release in 1 bottle59651-001-30Aurobindo PharmaIndia19 August 2015
10 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack59651-001-78Aurobindo PharmaIndia19 August 2015
1000 capsule, delayed release in 1 bottle59651-001-99Aurobindo PharmaIndia19 August 2015
100 capsule, delayed release in 1 bottle31722-527-01Camber PharmaceuticalsIndia26 September 2019
30 capsule, delayed release in 1 bottle31722-527-30Camber PharmaceuticalsIndia26 September 2019
100 capsule, delayed release in 1 bottle68462-395-01Glenmark PharmaceuticalsIndia1 October 2016
30 capsule, delayed release in 1 bottle68462-395-30Glenmark PharmaceuticalsIndia1 October 2016
90 capsule, delayed release in 1 bottle68462-395-90Glenmark PharmaceuticalsIndia1 October 2016
30 capsule, delayed release in 1 bottle62135-530-30Chartwell RX16 March 2023
90 capsule, delayed release in 1 bottle62135-530-90Chartwell RX16 March 2023
30 capsule, delayed release in 1 bottle62135-559-30Chartwell RX11 February 2025
100 capsule, delayed release in 1 bottle0781-2785-01Sandoz28 January 2003
1000 capsule, delayed release in 1 bottle0781-2785-10Sandoz28 January 2003
30 capsule, delayed release in 1 bottle0781-2785-31Sandoz28 January 2003
100 capsule, delayed release in 1 bottle0781-2859-01Sandoz1 August 2019
1000 capsule, delayed release in 1 bottle0781-2859-10Sandoz1 August 2019
30 capsule, delayed release in 1 bottle0781-2859-31Sandoz1 August 2019
90 capsule, delayed release in 1 bottle0781-2859-92Sandoz1 July 2019
100 capsule, delayed release in 1 bottle60505-0145-2Apotex11 November 2003
30 capsule, delayed release in 1 bottle62175-114-32Lannett3 September 2003

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 September 1989Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Omeprazole

Clinical summary

Omeprazole is a proton pump inhibitor indicated for the treatment of active duodenal ulcer in adults, among other approved uses. It is available as delayed-release capsules and delayed-release granules for oral use. MedsAcross supplies Omeprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Omeprazole

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Omeprazole 10 mg delayed-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.